Trial Information

Summary: Impaired Glucose Tolerance in Post-Menopausal Women

This is a research study of an approved medication for post-menopausal women with impaired glucose tolerance (pre-diabetes). The purpose of the study is to evaluate the effect of the study drug on bone density and metabolism. The study last approximately 19 months with about 8 visits to the Longmont Clinic. The physician in charge of this study is David Podlecki, M.D.

Criteria to participate:

• Age 70 or less
• At least 5 years post-menopausal
• Have impaired fasting blood sugar
• Generally healthy

The study provides:

• All study related or required exams including physicals, bone density testing, electrocardiograms, and laboratory tests
• Study medication
• Compensation for time and travel

If you would like to learn more about participating in this study, please send an e-mail message using the form below.